- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0000901

About Verdant Life Sciences Private Limited
Data last updated:
Verdant Life Sciences Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 09 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2008PTC059563. Its GSTIN is 37AACCV7514M1ZW (Andhra Pradesh).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.35 Cr. It is led by directors including Dharma Pracharak Ramineni (Managing Director) and Sivarama Prasad Manne.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.55 Jawaharlal Nehru Pharma City Thanam Revenue Village, Visakhapatnam, Andhra Pradesh, India – 530012.
As per the financials filed for FY 2025, the company reported a revenue of ₹89.48 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹67.24 Lakh (net margin 0.8%) and EBITDA of ₹7.13 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
The company has about 139 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Verdant Life Sciences. As per MCA filings, the company has open charges of ₹45.63 Cr and satisfied charges of ₹12.5 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹16.17 Cr; the latest was in September 2023. Its 8 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Gorakh Nath Formulations Private Limited with revenue of ₹89.91 Cr.
Verdant Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0000901). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website verdantpharma.com.
Company details
Recognitions & Rankings of Verdant Life Sciences
Contact details
Verdant Life Sciences Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is verdantpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.55 Jawaharlal Nehru Pharma City Thanam Revenue Village, Visakhapatnam, Andhra Pradesh, India – 530012
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Verdant Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Verdant Life Sciences operates one associated brand: Verdant Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients are manufactured for the biopharma sector. | verdantpharma.com |
Business activity
The main business activity of Verdant Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Verdant Life Sciences Private Limited, buy the company report.
Financials of Verdant Life Sciences Private Limited
FY 2025 filings availableVerdant Life Sciences Private Limited reported revenue of ₹89.48 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over three years, including 6% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Verdant Life Sciences Private Limited, buy the company report.
Board of directors of Verdant Life Sciences Private Limited
Verdant Life Sciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivarama Prasad Manne | Director | 27 Apr 2009 | 17 Years 6 Months | Current |
| Dharma Pracharak Ramineni Also directs: Hindustan Therapeutics Private Limited | Managing Director | 26 Apr 2013 | 13 Years 6 Months | Current |
| Ravindra Babu Gogineni Also directs: Meliora Therapeutics Private Limited | Director | 27 Apr 2009 | 17 Years 6 Months | Current |
Peer comparison
Verdant Life Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gorakh Nath Formulations Private Limited | ₹89.91 Cr (FY 2024) | -3.0% | Meerut, Uttar Pradesh, India | |||
| Agog Pharma Limited | ₹89.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India | |||
| Alcedo Pharmachem Private Limited | ₹89.55 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | 263.0% | New Delhi, Delhi, India | |||
| Verdant Life Sciences Private Limitedthis company | ₹89.48 Cr (FY 2025) | ₹67.24 Lakh | 0.8% | 6.0% | 139 | Visakhapatnam, Andhra Pradesh, India |
| Sam Fine O Chem Limited | ₹89.46 Cr (FY 2025) | 22.0% | Rajkot, Gujarat, India | |||
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | -2.0% | Indore, Madhya Pradesh, India | |||
| Evertogen Life Sciences Limited | ₹89.28 Cr (FY 2024) | 51.0% | Hyderabad, Telangana, India | |||
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | 421.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Verdant Life Sciences Private Limited, buy the company report.
Auditor
Verdant Life Sciences Private Limited is audited by RAMESH & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMESH & Co. | FY 2023 | 02979S |
Shareholding
The shareholding of Verdant Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Verdant Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Sep 2024 | 100988038 | Others | ₹2.5 Cr | Open | |
| 23 Mar 2022 | 100563612 | Others | ₹2.63 Cr | Open | |
| 31 Jan 2022 | 100542261 | Others | ₹5 Cr | Open | |
| 05 Oct 2020 | 100382761 | Others | ₹4.5 Cr | Open | |
| 29 Jan 2014 | 10474968 | Others | ₹31 Cr | Open |
To see the full charge records of Verdant Life Sciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Verdant Life Sciences Private Limited has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹16.17 Cr; the latest was in September 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Aug 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Jan 2014 | Funding round | ₹7.49 Cr | Investors: an individual |
To see the full deal history of Verdant Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Verdant Life Sciences Private Limited has 2 court cases on record: 1 filed by Verdant Life Sciences, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal complaint | Filed against the company by The State of Andhra Pradesh Fire Service Dept. | Disposed |
To see the full case history of Verdant Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Verdant Life Sciences Private Limited was last rated by Care on 09 Jan 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 09 Jan 2026 |
To see the full credit ratings and regulatory alerts of Verdant Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Verdant Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Verdant Life Sciences Private Limited has a workforce of 139 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Verdant Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCV7514M1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Verdant Life Sciences Private Limited, buy the company report.
Recent activity
Verdant Life Sciences Private Limited has 8 board changes on record since 2009: 3 appointments and 5 cessations. The latest: Valiveti Brahmaji ceased to be Director on 07 Sep 2019.
8 earlier events are in the company report.
Frequently asked questions
Verdant Life Sciences is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 09 June 2008 (18+ years old) and is registered under CIN U24232AP2008PTC059563.
Verdant Life Sciences has 3 current directors:
- Dharma Pracharak Ramineni - Managing Director
- Sivarama Prasad Manne - Director
- Ravindra Babu Gogineni - Director
The latest financial statements of Verdant Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Verdant Life Sciences is 37AACCV7514M1ZW, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Verdant Life Sciences is U24232AP2008PTC059563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Verdant Life Sciences has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Verdant Life Sciences was incorporated on 09 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Vijayawada.
Verdant Life Sciences has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹16.17 Cr; the latest was in September 2023.
The peers of Verdant Life Sciences by revenue are Gorakh Nath Formulations Private Limited, Agog Pharma Limited, Alcedo Pharmachem Private Limited, Shrey Nutraceuticals and Herbals Private Limited, Sam Fine O Chem Limited and 3 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Valiveti Brahmaji ceased to be Director on 07 Sep 2019. Dharma Pracharak Ramineni ceased to be Director on 09 Jul 2014. Dharma Pracharak Ramineni was appointed as Managing Director on 26 Apr 2013. Verdant Life Sciences has 8 board changes on record in total.
Yes, Verdant Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0000901).

